| (210) | Number of the EPO application | 18717731 |
| (220) | Filing date of the EPO application | 2018.04.03 |
| (110) | EPO patent number | 3600411 |
| (21) | Number of the application | e 2020 0130 |
| (71) | Name(s) of applicant(s), code of the country | Merus B.V., NL; |
| (72) | Name(s) of inventor(s), code of the country | THROSBY Mark, NL;
GEUIJEN Cecilia Anna Wilhelmina, NL;
MAUSSANG-DETAILLE David Andre Baptiste, NL;
LOGTENBERG Ton, NL; |
| (54) | Title of the invention | ANTIBODIES FOR THE TREATMENT OF ERBB-2/ERBB-3 POSITIVE TUMORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 39/395 (2006.01.01); C07K 16/28 (2006.01.01); C07K 16/32 (2006.01.01); C07K 16/46 (2006.01.01) |
| (52) | Cooperative Patent Classification | C07K 16/468 (EP); A61K 39/39558 (EP); C07K 16/2863 (EP); C07K 16/32 (EP); A61K 2039/505 (EP); C07K 2317/21 (EP); C07K 2317/31 (EP); C07K 2317/52 (EP) |
| (19) | Country | NL |
| (41) | Date of publication of the application | 2020.03.31 |
| (30) | Priority | 17164382, 2017.03.31, EP |
| (86) | International application | PCT/NL2018/050204, 2018.04.03 |
| (87) | International publication | WO 2018/182420, 2018.10.04 |